Fresenius Medical Care AG & Co. KGaA (FME) — Capital Reinvestment Ratio
Fresenius Medical Care AG & Co. KGaA (FME) has a Capital Reinvestment Ratio of 0.28x as of June 2026, meaning it reinvests 0% of its operating cash flow (€860.30 Million) in capital expenditures (€240.40 Million). Check tangible net worth ratio of Fresenius Medical Care AG & Co. KGaA to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio (1998–2025)
This chart tracks Fresenius Medical Care AG & Co. KGaA's Capital Reinvestment Ratio across 28 annual periods. For the full cash flow conversion analysis, see Fresenius Medical Care AG & Co. KGaA cash flow conversion.
Annual Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA (1998–2025)
Year-by-year Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA from 1998 to 2025. See FME free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €2.68 Billion | €915.37 Million | ▲ +16.5% |
| 2024 | 0.29x | €2.39 Billion | €699.36 Million | ▲ +12.5% |
| 2023 | 0.26x | €2.63 Billion | €684.60 Million | ▼ -60.0% |
| 2022 | 0.65x | €2.17 Billion | €1.41 Billion | ▼ -3.7% |
| 2021 | 0.68x | €2.49 Billion | €1.68 Billion | ▲ +37.1% |
| 2020 | 0.49x | €4.23 Billion | €2.09 Billion | ▼ -43.4% |
| 2019 | 0.87x | €2.57 Billion | €2.24 Billion | ▼ -12.7% |
| 2018 | 1.00x | €2.06 Billion | €2.06 Billion | ▲ +22.7% |
| 2017 | 0.81x | €2.19 Billion | €1.78 Billion | ▼ -14.7% |
| 2016 | 0.95x | €2.03 Billion | €1.94 Billion | ▼ -0.9% |
| 2015 | 0.96x | €1.79 Billion | €1.73 Billion | ▼ -3.2% |
| 2014 | 1.00x | €1.53 Billion | €1.52 Billion | ▲ +170.7% |
| 2013 | 0.37x | €1.47 Billion | €541.64 Million | ▲ +11.0% |
| 2012 | 0.33x | €1.54 Billion | €510.63 Million | ▼ -79.9% |
| 2011 | 1.65x | €1.12 Billion | €1.84 Billion | ▲ +330.6% |
| 2010 | 0.38x | €1.03 Billion | €393.72 Million | ▼ -10.7% |
| 2009 | 0.43x | €934.57 Million | €400.63 Million | ▼ -36.6% |
| 2008 | 0.68x | €730.12 Million | €493.76 Million | ▲ +40.0% |
| 2007 | 0.48x | €822.75 Million | €397.56 Million | ▼ -6.1% |
| 2006 | 0.51x | €687.85 Million | €353.99 Million | ▲ +9.6% |
| 2005 | 0.47x | €565.94 Million | €265.76 Million | ▲ +39.5% |
| 2004 | 0.34x | €610.68 Million | €205.62 Million | ▼ -12.8% |
| 2003 | 0.39x | €598.71 Million | €231.27 Million | ▼ -11.2% |
| 2002 | 0.43x | €524.06 Million | €227.91 Million | ▼ -33.0% |
| 2001 | 0.65x | €476.82 Million | €309.33 Million | ▲ +11.3% |
| 2000 | 0.58x | €416.60 Million | €242.80 Million | ▲ +27.6% |
| 1999 | 0.46x | €348.80 Million | €159.28 Million | ▼ -67.9% |
| 1998 | 1.42x | €228.51 Million | €325.38 Million | — |